Target intelligence / Profile preview

Colonic bacteria and luminal osmolarity

Molecular classification
Other
01

Overview

Colonic bacteria and luminal osmolarity refers to the physiological environment of the large intestine, which serves as a functional target for osmotic laxatives and ammonia-reducing agents (StatPearls, 2023). This system involves the metabolic interaction between the gut microbiota and non-absorbable solutes within the intestinal lumen (Nature Reviews Drug Discovery, 2017). Drugs such as lactulose are fermented by colonic bacteria (e.g., Lactobacillus and Bifidobacterium) into organic acids like lactic and acetic acid, which significantly increases luminal osmolarity and decreases pH (PubChem, CID 11333). The resulting osmotic gradient draws water into the colon, increasing stool volume and stimulating peristalsis (Mayo Clinic, 2023). Furthermore, the acidification of the lumen traps ammonia (NH3) as ammonium ions (NH4+), preventing its systemic absorption and aiding in the management of hepatic encephalopathy (American Journal of Gastroenterology, 2014). This complex interplay between microbial metabolism and physical chemistry is essential for maintaining gastrointestinal health and systemic metabolic balance. Consequently, modulating this environment is a critical therapeutic focus for treating chronic constipation and metabolic disorders associated with liver dysfunction.

Other names
Gut microbiotaIntestinal floraColonic osmotic environmentLuminal osmotic pressure
02

Mechanism of action

Osmotic laxatives increase luminal osmolarity by retaining water through osmotic pressure; prebiotics like lactulose are fermented by colonic bacteria into organic acids, further increasing osmolarity and lowering pH (StatPearls, 2023; PubChem, 2024).

03

Biological functions

MetabolismOsmoregulationFluid balanceFermentationAmmonia detoxification
04

Disease associations

ConstipationHepatic encephalopathyDysbiosisIrritable bowel syndrome
05

Safety considerations

Electrolyte imbalanceDehydrationAbdominal distensionFlatulenceDiarrhea
06

Interacting drugs

Lactulose

5 more in the full profile.

07

Biomarkers

Bristol Stool Scale (BSS)Fecal pHFecal osmolarityBlood ammonia levels

Beyond the preview

Go deeper on Colonic bacteria and luminal osmolarity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonic bacteria and luminal osmolarity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call